Early research (Phase 1)Ended earlyNCT02078752What this trial is testingPF-06647263 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsTriple-Negative Breast Cancer Pfizer 60
Early research (Phase 1)Active Not RecruitingNCT03401385What this trial is testingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Who this might be right forHormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer Daiichi Sankyo Co., Ltd. 890
Large-scale testing (Phase 3)Active Not RecruitingNCT06519370What this trial is testingFDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerWho this might be right forTriple Negative Breast Cancer Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 350
Testing effectiveness (Phase 2)Looking for participantsNCT06224673What this trial is testingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerWho this might be right forHER2 Low Breast CarcinomaTriple Negative Breast CancerHormone-receptor-positive Breast Cancer+1 more Laura Huppert, MD, BA 36
Early research (Phase 1)Study completedNCT04293094What this trial is testingStudy of AMG 650 in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Volastra Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Looking for participantsNCT06878625What this trial is testingA Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast CancerWho this might be right forEvaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer Tianjin Medical University Cancer Institute and Hospital 138
Testing effectiveness (Phase 2)Study completedNCT05001347What this trial is testingA Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid TumorsWho this might be right forOvarian CancerHead and Neck CancerNon Small Cell Lung Cancer+3 more I-Mab Biopharma US Limited 25
Testing effectiveness (Phase 2)Study completedNCT02018458What this trial is testingSafety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast CancerWho this might be right forBreast Cancer Baylor Research Institute 10
Large-scale testing (Phase 3)Study completedNCT05555706What this trial is testingStudy of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer (TNBC) Shanghai Jiaolian Drug Research and Development Co., Ltd 62
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)UnknownNCT05955105What this trial is testingILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesWho this might be right forHead and Neck CancerCervical CancerEndometrial Cancer+7 more Innolake Biopharm 200
Testing effectiveness (Phase 2)Study completedNCT03310957What this trial is testingSafety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast CancerWho this might be right forTriple Negative Breast Neoplasms Seagen Inc. 185
Early research (Phase 1)Study completedNCT03071757What this trial is testingThe Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 139
Not applicableLooking for participantsNCT07391956What this trial is testingTier Palliative Care For Patients With Advanced Heart Failure or CancerWho this might be right forAdvanced Heart FailureAdvanced Non-Colorectal Gastrointestinal CancerAdvanced Lung Cancer+1 more Icahn School of Medicine at Mount Sinai 400
Early research (Phase 1)Study completedNCT03101280What this trial is testingA Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast CancerWho this might be right forGynecologic Neoplasms Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT02527434What this trial is testingStudy of Tremelimumab in Patients With Advanced Solid TumorsWho this might be right forUrothelial Bladder CancerTriple-negative Breast CancerPancreatic Ductal Adenocarcinoma AstraZeneca 64
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11
Early research (Phase 1)Study completedNCT03800836What this trial is testingEvaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 139
Testing effectiveness (Phase 2)WithdrawnNCT03644589What this trial is testingEffect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more University of Washington
Testing effectiveness (Phase 2)Looking for participantsNCT06636981What this trial is testingAll Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II TrialWho this might be right forTriple Negative Breast Cancer (TNBC) Fudan University 129